[The treatment of incipient diabetic nephropathy (2nd of 2 parts)].
Besides diabetic patients are controlled with glycosylated hemoglobins not exceeding 7% and the normalization of blood pressure with some hypotensive drugs, it has been noted the important role of protein restriction in diet in order to retard nephropathy progression. For some years, various aldose reductase inhibitors (ARIs) have been used, which avoid the accumulation of sorbitol in tissues as well as complications. Platelet antiaggregants are also used for the treatment of diabetic nephropathy, but at a lower level.
Pérez Blanco
F J
FJ
Departamento de Medicina Interna, Hospital Universitario San Cecilio, Granada.
Manzanares
L
L
Moreno
G
G
Cabello
M J
MJ
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D003928:Diabetic Nephropathies / Q000628:therapy*; D018753:Diet, Protein-Restricted; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D000449:Aldehyde Reductase
Consideraciones sobre el tratamiento de la nefropatía diabética incipiente (segunda de dos partes).